Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04951310 · ClinicalTrials.gov registry record · NA
COVID-19 Vaccinations With a Sweepstakes
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 3,827,656
- Enrollment target
NCT04951310: Completed NA study, sponsored by University of Pennsylvania.
NCT04951310 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 3,827,656 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04951310, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,827,656 participants
- Enrollment target
Study Summary
To reach herd immunity for COVID-19, experts estimate that 70% of the population will need to be vaccinated. However, vaccination rates have begun to slow down in the United States. The investigators will partner with Philadelphia to launch a COVID-19 vaccination sweepstakes, in which residents will be eligible to win if they have received at least one dose of the COVID-19 vaccine prior to a given drawing. Drawings will be held every two weeks; multiple prizes of various sizes will be awarded in each drawing. Half of the prizes in each size category in each drawing will be awarded to residents of a zip code that is randomly selected from a pre-defined list of under-vaccinated zip codes (this zip code will be announced at the start of each 2-week drawing period), the other half will be awarded to residents outside of that selected zip code. The investigators will analyze vaccination rates in Philadelphia as compared with neighboring regions before, during, and after the specified time period, as well as analyze vaccination rates in the three selected zip codes compared to the other zip codes that could have been targeted (the residual set of under-vaccinated zip codes) to determine the effectiveness of the sweepstakes at encouraging vaccinations.
Interventions
- BEHAVIORAL Philly Vax Sweepstakes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,827,656 participants |
| Start Date | 2021-06-07 |
| Est. Completion | 2021-08-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04951310
The ClinicalTrials.gov registry entry for NCT04951310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,827,656 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Philly Vax Sweepstakes is the first listed.
NCT04951310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04951310 about?
NCT04951310 is a clinical study titled "COVID-19 Vaccinations With a Sweepstakes". To reach herd immunity for COVID-19, experts estimate that 70% of the population will need to be vaccinated. However, vaccination rates have begun to slow down in the United States. The investigators will partner with Philadelphia to launch a COVID-19 vaccination sweepstakes, in which residents will...
What is the current status of trial NCT04951310?
This trial is currently completed. It is a NA study. The enrollment target is 3,827,656 participants. The study started on 2021-06-07. Estimated completion is 2021-08-14.
What interventions are being tested in trial NCT04951310?
The interventions under investigation include: Philly Vax Sweepstakes (BEHAVIORAL).
Who is sponsoring clinical trial NCT04951310?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.